Literature DB >> 12672182

Systemic and local expression of perforin in lymphocyte subsets in acute and chronic rheumatoid arthritis.

Gordan Gulan1, Jagoda Ravlic-Gulan, Natasa Strbo, Vlatka Sotosek, Boris Nemec, Damir Matovinovic, Dusan Rubinic, Eckhard R Podack, Daniel Rukavina.   

Abstract

OBJECTIVE: To investigate the role of the cytolytic action mediated by perforin in the course of rheumatoid arthritis (RA), we studied the immunophenotypic characteristics of lymphocytes containing perforin in peripheral blood (systemic level), in synovial fluid (SF), and in the synovial membrane (local level) in patients during the acute or chronic phase of RA. Cells from patients with osteoarthritis were used as controls.
METHODS: Flow cytometry was used for simultaneous detection of intracellular (perforin) and cell surface antigens. Mean fluorescence intensity (MFI) was a measure of the mean perforin content per cell. Immunocytochemical staining was used to visualize perforin in the cytoplasmic compartment of cells.
RESULTS: In acute RA highly significant changes in perforin expression were found in all compartments (peripheral blood, SF, and synovial membrane): (1) increase of percentage of total perforin positive cells; (2) increase of both subsets of cytolytic cells, T (CD8+P+) and NK (CD56+P+) cells; (3) increase in the frequency of perforin positive cells in CD8+ and CD56+ cell populations; and (4) the highest content of perforin/cell (MFI values) in all compartments, except in the synovial membrane.
CONCLUSION: Perforin positive cells may participate in the acute phase of RA by maintaining and perpetuating inflammation and contributing to tissue destruction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672182

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome.

Authors:  Martin Steinau; Elizabeth R Unger; Suzanne D Vernon; James F Jones; Mangalathu S Rajeevan
Journal:  J Mol Med (Berl)       Date:  2004-10-14       Impact factor: 4.599

Review 2.  The spectrum of large granular lymphocyte leukemia and Felty's syndrome.

Authors:  Xin Liu; Thomas P Loughran
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

Review 3.  CD30: from basic research to cancer therapy.

Authors:  Hiromi Muta; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.

Authors:  Heiko Bruns; Christoph Meinken; Philipp Schauenberg; Georg Härter; Peter Kern; Robert L Modlin; Christian Antoni; Steffen Stenger
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

5.  STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.

Authors:  Andres Jerez; Michael J Clemente; Hideki Makishima; Hanna Koskela; Francis Leblanc; Kwok Peng Ng; Thomas Olson; Bartlomiej Przychodzen; Manuel Afable; Ines Gomez-Segui; Kathryn Guinta; Lisa Durkin; Eric D Hsi; Kathy McGraw; Dan Zhang; Marcin W Wlodarski; Kimmo Porkka; Mikkael A Sekeres; Alan List; Satu Mustjoki; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

6.  Identification of novel regulators in T-cell differentiation of aplastic anemia patients.

Authors:  Anke Franzke; Robert Geffers; J Katrin Hunger; Susanne Pförtner; Wenji Piao; Philipp Ivanyi; Jens Grosse; Michael Probst-Kepper; Arnold Ganser; Jan Buer
Journal:  BMC Genomics       Date:  2006-10-19       Impact factor: 3.969

Review 7.  Persistent Large Granular Lymphocyte Clonal Expansions: "The Root of Many Evils"-And of Some Goodness.

Authors:  Carlos Bravo-Pérez; Salvador Carrillo-Tornel; Esmeralda García-Torralba; Andrés Jerez
Journal:  Cancers (Basel)       Date:  2022-03-05       Impact factor: 6.639

8.  Determination of quantitative and site-specific DNA methylation of perforin by pyrosequencing.

Authors:  Supraja Narasimhan; Virginia R Falkenberg; Maung M Khin; Mangalathu S Rajeevan
Journal:  BMC Res Notes       Date:  2009-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.